Bills to limit pharmacy benefit managers have been among the most popular and bipartisan pieces of legislation introduced in Congress during the last two years, yet none have passed.

Bob Lane, a prostate cancer survivor and patient receiving Erleada (apalutamide), understands firsthand the challenges men face when discussing prostate cancer.

We’ve all experienced common issues like headaches, vision changes, nausea, stomach pain, and mouth sores.

A string of recent rural health clinic closures is threatening to further reduce access to care in outlying areas as health systems brace for cuts in the in the Republican budget law and grapple with inflation and workforce issues.

There can be a sense of fatalism surrounding cancer.

“Liquid biopsy” tests using blood samples to screen for multiple types of cancer are attracting much attention, for their potential to catch unseen tumors.

Health insurance premiums in the United States are headed toward a sharp increase in 2026, the biggest leap in about 15 years.

A new study shows that contrast enhanced ultrasound (CEUS) techniques offer an encouraging option for noninvasively detecting pancreatic cancer in its early stages, when treatment may help save lives, according to results presented today at the 39th annual International Bubble Conference in Chicago.

“It is a nightmare waking up every day wondering if some people halfway across the country will approve what my doctors have said is my only chance.”

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or considered during appointments with their primary-care clinicians to discuss a common screening test.